AMPK |
AMP-activated protein kinase |
Ang-2 |
Angiopoietin-2 |
APC |
Antigen-presenting cell |
ASC |
Adipose stromal cell, Adipose-derived stem cell |
ASCO |
American Society of Clinical Oncology |
α-SMA |
Alpha smooth muscle actin |
ATGL |
Adipocyte triglyceride lipase |
ATM |
Adipose tissue macrophages |
BAI |
Body Adiposity Index |
BMI |
Body mass index |
CAA |
Cancer-associated adipocytes |
CAFs |
Cancer-associated fibroblasts |
CCK |
Cholecystokinin |
CLS |
Crown like structure |
COX-2 |
Cyclooxygenase-2 |
CPT1 |
Carnitine palmitoyltransferase 1 |
DAMPs |
Damage-associated molecular patterns |
DCIS |
Ductal carcinoma in situ |
ECM |
Extracellular matrix |
EMT |
Epithelial-to-mesenchymal transition |
FACS |
Fluorescence activated cell sorting |
FGF-2 |
Fibroblast growth factor 2 |
GEMM |
Genetically engineered mouse model |
HGF |
Hepatocyte growth factor |
HIF-1, HIF-1α |
Hypoxia-inducible factor, 1α subunit |
IDC |
Invasive ductal carcinoma |
IGF-1 |
Insulin-like growth factor-1 |
IL-6 |
Interleukin-6 |
ILCs |
Innate lymphoid cells |
ILC2s |
Innate lymphoid type 2 cells |
LVD |
Lymphatic vessel density |
M1, M2 |
Macrophage phenotypes |
MCP-1/CCL2 |
Monocyte-chemoattractant protein, also called CC chemokine ligand 2 |
MMP |
Matrix metalloprotease |
MMTV-PyMT |
Mouse mammary tumor virus, Polyoma middle T antigen |
N1, N2 |
Subtypes of tumor-associated neutrophils (see TAN) |
NF-κB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
NHANES |
United States National Health and Nutrition Examination Survey |
NK |
cells Natural killer cells |
PAI-1 |
Plasminogen activator inhibitor-1 |
PD-1 |
Programmed Death-1 |
PDGF |
Platelet-derived growth factor |
PD-L1 |
Programmed death-1 ligand |
PGE2
|
Prostaglandin E2 |
PIN |
Prostatic intraepithelial neoplasia |
PPARγ |
Peroxisome proliferator-activated receptor gamma |
TAM |
Tumor-associated macrophage |
TAN |
Tumor-associated neutrophil |
TCR |
T cell receptor |
TDLU |
Terminal ductal lobular unit |
TEB |
Terminal end bud |
TGF-β |
Transforming growth factor beta |
Th1, Th2, |
Th17 T helper cell subtypes |
TNBC |
Triple negative breast cancer |
TNFα |
Tumor necrosis factor alpha |
Tregs |
Regulatory T cells |
VEGF |
Vascular endothelial growth factor |